Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | KIF11 | P52732 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10684188 | 0.97 | SMN1; SMN2 (0.50) | TAAR1KIF11SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL28346415 | 0.93 | TAAR1 (0.46) | TAAR1KIF11SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL26930170 | 0.87 | KIF11 (0.44) | TAAR1KIF11SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL9181282 | 0.82 | KIF11 (0.44) | TAAR1KIF11CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL11181214 | 0.80 | KIF11 (0.56) | KIF11SMN1; SMN2CYP2D6CHRM2CHRM1 | |
| SCHEMBL10505123 | 0.79 | CYP1A2 (0.56) | TAAR1KIF11SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL135745 | 0.79 | TAAR1 (0.52) | TAAR1KIF11SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL2066034 | 0.78 | MEN1 (0.55) | TAAR1KIF11SMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL2199869 | 0.78 | KIF11 (0.58) | TAAR1KIF11CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL560935 | 0.78 | SMN1; SMN2 (0.61) | KIF11SMN1; SMN2CYP2C9CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1087348-C | Pacemate separation of primary and secondary heteroatom-substituted amine by enzyme-catalysed acylation | BASF AG (DE) | 2002-07-10 | — | — | CN | claimed |
| JP-3097780-A | — | — | None | — | — | JP | disclosed |
| US-20250381762-A1 | VERMICULITE LAMINATED FILM FOR VACUUM INSULATION PANEL, VACUUM INSULATION PANEL HAVING THE SAME AND REFRIGERATOR | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-12-18 | — | — | US | disclosed |
| EP-4036082-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2022-08-03 | — | — | EP | disclosed |
| US-9873702-B2 | Heterocyclic compounds as biogenic amine transport modulators | SOUTHERN RESEARCH INSTITUTE (US) | 2018-01-23 | — | — | US | disclosed |
| CN-105859685-A | Method for preparing dexrabeprazole sodium | 山东裕欣药业有限公司 | 2016-08-17 | — | — | CN | disclosed |
| US-20160159809-A1 | HETEROCYCLIC COMPOUNDS AS BIOGENIC AMINE TRANSPORT MODULATORS | SOUTHERN RESEARCH INSTITUTE | 2016-06-09 | — | — | US | disclosed |
| EP-1373167-B1 | SOLID PHASE SYNTHESIS SUPPORTS AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2015-12-09 | — | — | EP | disclosed |
| EP-1753711-B1 | METHOD FOR PRODUCING QUATERNARY AMMONIUM COMPOUNDS | BASF SE (DE) | 2015-07-08 | — | — | EP | disclosed |
| US-8871317-B2 | Curable adhesive system, method of assembly of distinct components therewith | TEKNOR APEX COMPANY (US) | 2014-10-28 | — | — | US | disclosed |
| EP-0233686-A3 | BIS PHENYL ETHANOL AMINES AND BIS PHENYOXYPROPANOLAMINES HAVING A BETA-AGONIST ACTIVITY | BEECHAM GROUP PLC (GB) | 1989-05-03 | — | — | EP | disclosed |
| EP-0139358-B1 | N6-SUBSTITUTED DIARYLALKYL ADENOSINES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | WARNER-LAMBERT COMPANY (US) | 1988-11-09 | — | — | EP | disclosed |
| EP-0251339-A2 | N6- substituted diarylalkyl adenosines, processes for their production and pharmaceutical compositions comprising the same | WARNER-LAMBERT COMPANY (US) | 1988-01-07 | — | — | EP | disclosed |
| EP-0233686-A2 | Bis phenyl ethanol amines and bis phenyoxypropanolamines having a beta-agonist activity | BEECHAM GROUP PLC (GB) | 1987-08-26 | — | — | EP | disclosed |
| EP-0226475-A1 | Diphenoxyethyl amine derivatives, process for their preparation and pharmaceutical compositions containing them | Albert ROLLAND S.A. Société dite (FR) | 1987-06-24 | — | — | EP | disclosed |
| US-4657897-A | N6 -substituted adenosines for treating pain | WARNER-LAMBERT COMPANY (US) | 1987-04-14 | — | — | US | disclosed |
| US-4657898-A | CARDIOVACULAR AND PSYCHOLOGICAL DISORDERS, ANALGESICS, OR SEDATIVES | WARNER-LAMBERT COMPANY (US) | 1987-04-14 | — | — | US | disclosed |
| EP-0139358-A2 | N6-substituted diarylalkyl adenosines, processes for their production and pharmaceutical compositions comprising the same | WARNER-LAMBERT COMPANY (US) | 1985-05-02 | — | — | EP | disclosed |
| US-4111917-A | POLYURETHANES | W. R. GRACE & CO. (US) | 1978-09-05 | — | — | US | disclosed |
| US-3983289-A | EPOXIDIZED ALKADIENE ALCOHOL ESTER OF POLYCARBOXYLIC ACID, B-STAGE RESIN | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159809-A1 | HETEROCYCLIC COMPOUNDS AS BIOGENIC AMINE TRANSPORT MODULATORS | SLC18A2, SLC6A2, SLC6A3 | TAAR1 11/4885KIF11 1916/4885SMN1; SMN2 1029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.